184 related articles for article (PubMed ID: 30924090)
41. Induction of pluripotent stem cells transplantation therapy for ischemic stroke.
Jiang M; Lv L; Ji H; Yang X; Zhu W; Cai L; Gu X; Chai C; Huang S; Sun J; Dong Q
Mol Cell Biochem; 2011 Aug; 354(1-2):67-75. PubMed ID: 21465238
[TBL] [Abstract][Full Text] [Related]
42. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
[TBL] [Abstract][Full Text] [Related]
43. Promise of human induced pluripotent stem cells in skin regeneration and investigation.
Ohyama M; Okano H
J Invest Dermatol; 2014 Mar; 134(3):605-609. PubMed ID: 24132166
[TBL] [Abstract][Full Text] [Related]
44. Clinical trials in stem cell transplantation: guidelines for scientific and ethical review.
Lo B; Kriegstein A; Grady D
Clin Trials; 2008; 5(5):517-22. PubMed ID: 18827044
[TBL] [Abstract][Full Text] [Related]
45. PET demonstrates functional recovery after transplantation of induced pluripotent stem cells in a rat model of cerebral ischemic injury.
Wang J; Chao F; Han F; Zhang G; Xi Q; Li J; Jiang H; Wang J; Yu G; Tian M; Zhang H
J Nucl Med; 2013 May; 54(5):785-92. PubMed ID: 23503731
[TBL] [Abstract][Full Text] [Related]
46. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
Shtrichman R; Germanguz I; Itskovitz-Eldor J
Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
[TBL] [Abstract][Full Text] [Related]
47. Induced human pluripotent stem cells and advanced therapies: future perspectives for the treatment of haemophilia?
Liras A
Thromb Res; 2011 Jul; 128(1):8-13. PubMed ID: 21396685
[TBL] [Abstract][Full Text] [Related]
48. Aging in the mouse and perspectives of rejuvenation through induced pluripotent stem cells (iPSCs).
Isobe K; Cheng Z; Ito S; Nishio N
Results Probl Cell Differ; 2012; 55():413-27. PubMed ID: 22918818
[TBL] [Abstract][Full Text] [Related]
49. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.
Liu K; Ji G; Mao J; Liu M; Wang L; Chen C; Liu L
Cell Reprogram; 2012 Dec; 14(6):505-13. PubMed ID: 23035653
[TBL] [Abstract][Full Text] [Related]
50. Preclinical studies for induced pluripotent stem cell-based therapeutics.
Harding J; Mirochnitchenko O
J Biol Chem; 2014 Feb; 289(8):4585-93. PubMed ID: 24362021
[TBL] [Abstract][Full Text] [Related]
51. Autophagy activation promotes the effect of iPSCs-derived NSCs on bladder function restoration after spinal cord injury.
Shao R; Zhang L; Yang H; Wang Y; Zhang Z; Yue J; Chen Y; Pan H; Zhou H; Quan R
Tissue Cell; 2021 Oct; 72():101596. PubMed ID: 34333229
[TBL] [Abstract][Full Text] [Related]
52. Translational prospects for human induced pluripotent stem cells.
Csete M
Regen Med; 2010 Jul; 5(4):509-19. PubMed ID: 20632855
[TBL] [Abstract][Full Text] [Related]
53. The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies.
Scheiner ZS; Talib S; Feigal EG
J Biol Chem; 2014 Feb; 289(8):4571-7. PubMed ID: 24362036
[TBL] [Abstract][Full Text] [Related]
54. Do we still need human embryonic stem cells for stem cell-based therapies? Epistemic and ethical aspects.
Hug K; Hermerén G
Stem Cell Rev Rep; 2011 Nov; 7(4):761-74. PubMed ID: 21461713
[TBL] [Abstract][Full Text] [Related]
55. A commentary on iPS cells: potential applications in autologous transplantation, study of illnesses and drug screening.
Romano G; Morales F; Marino IR; Giordano A
J Cell Physiol; 2014 Feb; 229(2):148-52. PubMed ID: 23881704
[TBL] [Abstract][Full Text] [Related]
56. Reprogrammed cells for disease modeling and regenerative medicine.
Cherry AB; Daley GQ
Annu Rev Med; 2013; 64():277-90. PubMed ID: 23327523
[TBL] [Abstract][Full Text] [Related]
57. Bioluminescent Tracking of Human Induced Pluripotent Stem Cells In Vitro and In Vivo.
Nishimura T; Niizuma K; Nakauchi H
Methods Mol Biol; 2022; 2524():291-297. PubMed ID: 35821480
[TBL] [Abstract][Full Text] [Related]
58. MECHANISMS IN ENDOCRINOLOGY: Towards the clinical translation of stem cell therapy for type 1 diabetes.
Espes D; Lau J; Carlsson PO
Eur J Endocrinol; 2017 Oct; 177(4):R159-R168. PubMed ID: 28487297
[TBL] [Abstract][Full Text] [Related]
59. Potential applications of induced pluripotent stem cells (iPSCs) in hepatology research.
Sun C; Wilson GS; Fan JG; Qiao L
Curr Stem Cell Res Ther; 2015; 10(3):208-15. PubMed ID: 25599714
[TBL] [Abstract][Full Text] [Related]
60. Stem Cell Transplantation Therapy for Retinal Degenerative Diseases.
Han F; Xu G
Adv Exp Med Biol; 2020; 1266():127-139. PubMed ID: 33105499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
